- Previous Close
638.85 - Open
637.85 - Bid 672.20 x --
- Ask 677.00 x --
- Day's Range
618.95 - 697.00 - 52 Week Range
568.05 - 966.00 - Volume
11,350 - Avg. Volume
5,307 - Market Cap (intraday)
38.027B - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
27.92 - EPS (TTM)
24.60 - Earnings Date Apr 28, 2025 - May 2, 2025
- Forward Dividend & Yield 0.50 (0.08%)
- Ex-Dividend Date Aug 16, 2024
- 1y Target Est
901.33
Rossari Biotech Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it provides poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. The company was founded in 1997 and is based in Mumbai, India.
www.rossari.com450
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: ROSSARI.BO
View MorePerformance Overview: ROSSARI.BO
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ROSSARI.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ROSSARI.BO
View MoreValuation Measures
Market Cap
35.37B
Enterprise Value
36.13B
Trailing P/E
25.99
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.80
Price/Book (mrq)
3.16
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
13.69
Financial Highlights
Profitability and Income Statement
Profit Margin
6.89%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
19.73B
Net Income Avi to Common (ttm)
1.36B
Diluted EPS (ttm)
24.60
Balance Sheet and Cash Flow
Total Cash (mrq)
800.08M
Total Debt/Equity (mrq)
14.38%
Levered Free Cash Flow (ttm)
--